CYTOSORBENTS CORPORATION Other Comprehensive Income (Loss), Net of Tax
CYTOSORBENTS CORPORATION (CTSO) reported Other Comprehensive Income (Loss), Net of Tax of $1.10 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-06
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was $1.10M.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was $876.00K.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was $867.00K, a 80.34% decline year-over-year.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $116.00K.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for fiscal 2025 was -$7.23M, a 294.17% decline from fiscal 2024.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for fiscal 2024 was $3.72M.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for fiscal 2014 was $283.69K.
- CYTOSORBENTS CORPORATION other comprehensive income (loss), net of tax for fiscal 2013 was -$43.33K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.10M 10-Q · filed 2026-08-06 | $1.98M 10-Q · filed 2026-08-06 | $2.85M derived: sum of 3 quarters · filed 2026-08-06 | $2.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $876.00K 10-Q · filed 2026-05-13 | $1.74M derived: sum of 2 quarters · filed 2026-05-13 | $1.86M derived: sum of 3 quarters · filed 2026-05-13 | -$3.62M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $867.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $983.00K derived: sum of 2 quarters · filed 2026-03-30 | -$4.49M derived: sum of 3 quarters · filed 2026-08-06 | -$7.23M 10-K · filed 2026-03-30 |
| 2025-09-30 | $116.00K 10-Q · filed 2025-11-13 | -$5.36M derived: sum of 2 quarters · filed 2026-08-06 | -$8.10M 10-Q · filed 2025-11-13 | -$3.69M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$5.48M 10-Q · filed 2026-08-06 | -$8.21M 10-Q · filed 2026-08-06 | -$3.80M derived: sum of 3 quarters · filed 2026-08-06 | -$6.13M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$2.74M 10-Q · filed 2026-05-13 | $1.67M derived: sum of 2 quarters · filed 2026-05-13 | -$657.00K derived: sum of 3 quarters · filed 2026-05-13 | -$236.00K derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $4.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $2.08M derived: sum of 2 quarters · filed 2026-03-30 | $2.50M derived: sum of 3 quarters · filed 2026-03-30 | $3.72M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$2.33M 10-Q · filed 2025-11-13 | -$1.91M derived: sum of 2 quarters · filed 2025-11-13 | -$686.00K 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $421.00K 10-Q · filed 2025-08-07 | $1.64M 10-Q · filed 2025-08-07 | ||
| 2014-12-31 | $160.50K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $278.54K derived: sum of 2 quarters · filed 2015-03-31 | $282.86K derived: sum of 3 quarters · filed 2015-03-31 | $283.69K 10-K · filed 2015-03-31 |
| 2014-09-30 | $118.03K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | $122.35K derived: sum of 2 quarters · filed 2014-11-12 | $123.18K 10-Q · filed 2014-11-12 | $42.94K derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-06-30 | $4.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-12 | $5.15K 10-Q · filed 2014-08-12 | -$75.09K derived: sum of 3 quarters · filed 2015-03-31 | -$34.91K derived: sum of 4 quarters · filed 2015-03-31 |
| 2014-03-31 | $833.00 10-Q · filed 2014-05-14 | -$79.41K derived: sum of 2 quarters · filed 2015-03-31 | -$39.22K derived: sum of 3 quarters · filed 2015-03-31 | -$40.09K derived: sum of 4 quarters · filed 2015-03-31 |
| 2013-12-31 | -$80.24K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | -$40.06K derived: sum of 2 quarters · filed 2015-03-31 | -$40.92K derived: sum of 3 quarters · filed 2015-03-31 | -$43.33K 10-K · filed 2015-03-31 |
| 2013-09-30 | $40.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $39.32K derived: sum of 2 quarters · filed 2013-11-06 | $36.91K 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$867.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-14 | -$3.27K 10-Q · filed 2013-08-14 | ||
| 2013-03-31 | -$2.40K 10-Q · filed 2013-05-15 | |||
| 2012-12-31 | -$12.66K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |